Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Despite China’s overall economy coming down with a bad cold last year, its EV players are upstaging the world’s most valuable auto company.
With military conflict continuing across the globe, and the world’s superpowers locked in a stare-down, it’s not easy being a global business
Apple — admitting no wrongdoing — has agreed to settle a class-action lawsuit that alleged Siri recorded users’ private conversations.